nach oben

Annals of Nuclear Medicine

Erschienen in:

20.06.2018 | Publisher Correction

Publisher Correction to: ¹⁸F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival

verfasst von: Aatif Parvez, Noam Tau, Douglas Hussey, Manjula Maganti, Ur Metser

Erschienen in: Annals of Nuclear Medicine | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Excerpt

Owing to an unfortunate mistake at Springer’s end, the title was incorrectly published as “⁷¹⁸F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival”. The correct title is given in this correction. …

Titel: Publisher Correction to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival
verfasst von: Aatif Parvez
Noam Tau
Douglas Hussey
Manjula Maganti
Ur Metser
Publikationsdatum: 20.06.2018
Verlag: Springer Japan
Erschienen in: Annals of Nuclear Medicine / Ausgabe 6/2018
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-018-1271-y

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate

Comparison of 125I- and 111In-labeled peptide probes for in vivo detection of oxidized low-density lipoprotein in atherosclerotic plaques

Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer

The correlation between striatal and cortical binding ratio of 11C-PiB-PET in amyloid-uptake-positive patients

Implications of electrocardiographic frontal QRS axis on left ventricular diastolic parameters derived from electrocardiogram-gated myocardial perfusion single photon emission computed tomography

Correction to: Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid